FDA Inspection 959775 — Michigan Reproductive Medicine

Michigan Reproductive Medicine — FEI 3006074124

The FDA completed an inspection of Michigan Reproductive Medicine on Dec 16, 2015 in Bloomfield Hills, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 16, 2015
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Bloomfield Hills, MI (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.